Arrivo Bio initiates phase 2b trial of SIRT6 activator for major depressive disorder
April 25, 2024 1 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The clinical trial of SP-624 is …